🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 día
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 25/11/1994 | 17,18 | 17,53 | 17,18 | 17,47 | +2,09% | 2,08% | 2.256.763 |
| 23/11/1994 | 17,12 | 17,24 | 17,00 | 17,12 | +0,35% | 1,39% | 6.050.942 |
| 22/11/1994 | 17,35 | 17,47 | 17,00 | 17,06 | -3,38% | 2,75% | 7.464.066 |
| 21/11/1994 | 17,95 | 18,07 | 17,59 | 17,65 | -1,99% | 2,66% | 5.231.826 |
| 18/11/1994 | 17,59 | 18,13 | 17,47 | 18,01 | +2,03% | 3,73% | 10.178.176 |
| 17/11/1994 | 17,83 | 18,07 | 17,47 | 17,65 | +0,00% | 3,34% | 8.393.432 |
| 16/11/1994 | 17,41 | 17,65 | 17,35 | 17,65 | +1,02% | 1,71% | 3.346.474 |
| 15/11/1994 | 17,71 | 17,77 | 17,35 | 17,47 | -1,68% | 2,36% | 4.974.856 |
| 14/11/1994 | 17,53 | 17,89 | 17,47 | 17,77 | +1,36% | 2,38% | 3.595.898 |
| 11/11/1994 | 17,71 | 17,77 | 17,53 | 17,53 | -1,01% | 1,35% | 4.919.941 |
| 10/11/1994 | 17,65 | 17,95 | 17,59 | 17,71 | +1,02% | 2,03% | 9.053.043 |
| 09/11/1994 | 17,53 | 17,59 | 17,41 | 17,53 | +2,80% | 1,02% | 10.744.515 |
| 08/11/1994 | 16,88 | 17,24 | 16,82 | 17,06 | +1,42% | 2,47% | 4.001.054 |
| 07/11/1994 | 16,76 | 16,82 | 16,58 | 16,82 | +0,36% | 1,42% | 2.910.925 |
| 04/11/1994 | 17,00 | 17,06 | 16,70 | 16,76 | -0,35% | 2,11% | 3.254.669 |
| 03/11/1994 | 16,82 | 16,88 | 16,70 | 16,82 | +0,36% | 1,06% | 2.360.725 |
| 02/11/1994 | 17,06 | 17,12 | 16,76 | 16,76 | -1,75% | 2,10% | 3.589.819 |
| 01/11/1994 | 16,94 | 17,18 | 16,88 | 17,06 | +0,35% | 1,76% | 3.653.118 |
| 31/10/1994 | 17,18 | 17,41 | 17,00 | 17,00 | -1,04% | 2,43% | 6.536.166 |
| 28/10/1994 | 16,94 | 17,18 | 16,82 | 17,18 | +1,41% | 2,11% | 5.066.032 |
| 27/10/1994 | 16,52 | 16,94 | 16,46 | 16,94 | +2,90% | 2,89% | 4.919.731 |
| 26/10/1994 | 16,46 | 16,52 | 16,22 | 16,46 | +0,00% | 1,81% | 4.323.838 |
| 25/10/1994 | 16,46 | 16,64 | 16,40 | 16,46 | -1,08% | 1,45% | 3.259.490 |
| 24/10/1994 | 16,94 | 17,00 | 16,52 | 16,64 | -1,76% | 2,82% | 3.436.811 |
| 21/10/1994 | 17,12 | 17,12 | 16,94 | 16,94 | -1,39% | 1,05% | 5.496.970 |
| 20/10/1994 | 17,00 | 17,18 | 16,94 | 17,18 | +1,41% | 1,40% | 4.735.493 |
| 19/10/1994 | 16,88 | 17,00 | 16,76 | 16,94 | +0,00% | 1,41% | 4.959.974 |
| 18/10/1994 | 17,29 | 17,35 | 16,94 | 16,94 | -1,73% | 2,41% | 6.871.107 |
| 17/10/1994 | 17,18 | 17,35 | 17,18 | 17,24 | -0,34% | 1,04% | 3.022.432 |
| 14/10/1994 | 17,47 | 17,53 | 17,18 | 17,29 | -1,02% | 2,05% | 5.271.859 |